| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-07-06 | coversin (recombinant protein derived from the saliva of the Ornithodoros moubata tick) | paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome | 1b | Akari Therapeutics (USA - NY - UK) | Rare diseases |
| 2016-07-06 | olipudase alfa | acid sphingomyelinase deficiency (ASMD), also known as Niemann-Pick disease type B | 2-3 | Sanofi Genzyme (USA - MA), a Sanofi company (France) | Rare diseases - Genetic diseases |
| 2016-07-06 | Debio 1143 - (5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide | epithelial ovarian cancer | 2 | Debiopharm (Switzerland) | Cancer - Oncology |
| 2016-07-05 | napabucasin (BBI608) | non squamous non cell lung cancer | 3 | Boston Biomedical (USA - MA) | Cancer - Oncology |
| 2016-07-03 | GS010- adeno-associated viral vector containing the human NADH dehydrogenase 4 gene | Leber hereditary optic neuropathy (LHON) | 1-2 | Gensight Biologics (France) | Ophtalmological diseases - Genetic diseases - Rare diseases |
| 2016-07-01 | ONCOS - 102 | malignant pleural mesothelioma | 1-2 | Targovax (Norway) | Cancer - Oncology |
| 2016-07-01 | ANYARA (naptumomab estafenatox) | renal cell cancer | 2-3 | Active Biotech (Sweden) | Cancer - Oncology |
| 2016-06-30 | AGS62P1 | acute myeloid leukemia | 1 | Astellas Pharma (Japan) Agensys (USA - CA) | Cancer - Oncology |
| 2016-06-30 | QGC001 | chronic heart failure | 2a | Quantum Genomics (France) | Cardiovascular diseases |
| 2016-06-30 | Ofev® (nintedanib) | idiopathic pulmonary fibrosis (IPF) | 3 | Boehringer Ingelheim (Germany) | Lung diseases - Respiratory diseases - Rare diseases |
| 2016-06-30 | SHP607 | retinopathy of prematurity | 2 | Shire (UK - USA) | Rare diseases |
| 2016-06-29 | Rydapt®(midostaurin - PKC412) | advanced systemic mastocytosis | 2 | Novartis (Switzerland) | Rare diseases |
| 2016-06-29 | GBT440 | sickle cell disease | 2a | Global Blood Therapeutics (USA - CA) | Rare diseases - Genetic diseases - Hematological diseases |
| 2016-06-28 | ND0612H | Parkinson's disease | 1 | Neuroderm (Israel) | Neurodegenerative diseases |
| 2016-06-28 | XOMA 213 | prolactinomas | 2 | Xoma (USA - CA) | Endocrinological diseases - Hormonal diseases |
| 2016-06-28 | pembrolizumab (MK-3475) | triple negative breast cancer (TNBC) | 3 | Merck&Co (USA - NJ) | Cancer - Oncology |
| 2016-06-27 | patiromer | hyperkalemia | 3 | Relypsa (USA - CA) | Cardiovascular diseases - Metabolic diseases |
| 2016-06-27 | Epidiolex® (cannabidiol (2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) | Lennox-Gastaut syndrome | 3 | Shire (UK - USA) | Rare diseases - CNS diseases - Neurological diseases |
| 2016-06-22 | Zika virus diagnostics | Zika virus infection | Avacta (UK) | Infectious diseases | |
| 2016-06-21 | Halaven® (eribulin) | unresectable locally advanced liposarcoma and leiomyosarcoma | 3 | Eisai (Japan) | Cancer - Oncology |
